American Lamprecht Enhances Visibility for Air and Ocean Shipments Using Descartes Solution
Notified -
Globe Newswire18-02-2025, 18:45
New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable 1-04-2025, 00:00